Valuation: UCB

Market Cap 4TCr 4.62TCr 3.78TCr 3.43TCr 6.43TCr 4,42700Cr 6.48TCr 45TCr 17TCr 2,24500Cr 17TCr 17TCr 7,16100Cr P/E 2026 *
21x
P/E 2027 * 17.3x
Enterprise Value 4.03TCr 4.65TCr 3.81TCr 3.45TCr 6.48TCr 4,46000Cr 6.53TCr 45TCr 17TCr 2,26200Cr 17TCr 17TCr 7,21600Cr EV / Sales 2026 *
4.64x
EV / Sales 2027 * 3.95x
Free-Float
61.59%
Yield 2026 *
0.69%
Yield 2027 * 0.72%
1 day-0.29%
1 week-0.19%
Current month-2.51%
1 month-1.13%
3 months-23.64%
6 months-15.91%
Current year-12.03%
1 week 200.7
Extreme 200.7
212.9
1 month 200.7
Extreme 200.7
226.2
Current year 200.7
Extreme 200.7
289.5
1 year 191.2
Extreme 191.2
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 01/01/2015
Director of Finance/CFO 60 01/07/2020
Chief Tech/Sci/R&D Officer 59 01/05/2024
Director TitleAgeSince
Director/Board Member 55 01/01/2012
Director/Board Member 67 01/01/2015
Director/Board Member 56 24/04/2014
Date Insider Type Main position Quantity % Market Cap. Importance
15/01/26 Exercice

Executive/Senior Manager

3,000 0.0015%
15/01/26 Exercice

Executive/Senior Manager

3,000 0.0015%
15/01/26 Buy

Director

500 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.29%-0.19%+1.21%+154.61% 4.63TCr
-2.47%-6.48%+38.23%-7.00% 7.93TCr
-1.99%-1.22%+511.53%+27.44% 5.86TCr
+1.57%+0.62%-16.15%-34.72% 5.86TCr
-0.56%-3.68%-11.53%+25.63% 4.87TCr
-0.55%-2.11%+49.23%-15.66% 3.21TCr
-0.37%-3.95%+46.50%+91.78% 2.48TCr
-1.91%-6.22%-2.91%+151.66% 2.15TCr
-1.92%-2.31%+62.94%+96.25% 1.6TCr
-5.51%-8.62%+33.55%+130.89% 1.41TCr
Average -1.15%-2.02%+71.26%+62.09% 4TCr
Weighted average by Cap. -0.73%-1.88%+89.21%+39.62%

Financials

2026 *2027 *
Net sales 869.48Cr 1TCr 821.08Cr 744.49Cr 1.4TCr 96TCr 1.41TCr 9.8TCr 3.77TCr 49TCr 3.77TCr 3.68TCr 1,55600Cr 967.67Cr 1.12TCr 913.8Cr 828.57Cr 1.55TCr 1,07000Cr 1.57TCr 11TCr 4.2TCr 54TCr 4.19TCr 4.1TCr 1,73200Cr
Net income 193.12Cr 222.86Cr 182.37Cr 165.36Cr 310.12Cr 21TCr 312.54Cr 2.18TCr 837.73Cr 11TCr 836.87Cr 818.46Cr 35TCr 232.47Cr 268.27Cr 219.53Cr 199.05Cr 373.3Cr 26TCr 376.22Cr 2.62TCr 1.01TCr 13TCr 1.01TCr 985.21Cr 42TCr
Net Debt 31Cr 35Cr 29Cr 26Cr 49Cr 3.38TCr 49Cr 344.48Cr 132.53Cr 1.71TCr 132.39Cr 129.48Cr 5.47TCr -180.78Cr -208.61Cr -170.71Cr -154.79Cr -290.29Cr -20TCr -292.56Cr -2.04TCr -784.16Cr -10TCr -783.36Cr -766.13Cr -32TCr
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,000
Date Price Change Volume
15/26/15 €209.90 -0.29% 1,96,985
14/26/14 €210.50 +2.38% 2,26,890
11/26/11 €205.60 +1.93% 2,47,334
10/26/10 €201.70 -1.42% 2,81,532
09/26/09 €204.60 -1.11% 2,62,195
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
209.90EUR
Average target price
285.00EUR
Spread / Average Target
+35.78%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!